Home
Scholarly Works
Æ-941, an inhibitor of angiogenesis: rationale for...
Journal article

Æ-941, an inhibitor of angiogenesis: rationale for development in combination with induction chemotherapy/radiotherapy in patients with non-small-cell lung cancer (nsclc)

Authors

Evans WK; Latreille J; Batist G; Falardeau P; Champagne P; Rivière M; Dupont E

Journal

European Journal of Cancer, Vol. 35, ,

Publisher

Elsevier

Publication Date

September 1, 1999

DOI

10.1016/s0959-8049(99)81412-9

ISSN

0959-8049

Contact the Experts team